Skip to main content

Dr. Arap is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Arap's full profile

Already have an account?

  • Office

    1 University Of New Mexico Msc 07 4025
    Albuquerque, NM 87131
    Phone+1 505-272-4946
    Fax+1 505-925-0100

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
  • Universidade de Sao Paulo Faculty of Medicine
    Universidade de Sao Paulo Faculty of MedicineClass of 1983

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • TX State Medical License
    TX State Medical License 2000 - 2022
  • NM State Medical License
    NM State Medical License 2013 - 2020
  • CT State Medical License
    CT State Medical License 1991 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2003

Publications & Presentations

PubMed

Journal Articles

  • Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease  
    Richard L Sidman, Leslie A Morrison, Howard Yonas, Wadih Arap, Muhammad O Chohan, JAMA

Press Mentions

  • Identifying Potential Treatment for Triple Negative Breast Cancer
    Identifying Potential Treatment for Triple Negative Breast CancerJune 1st, 2021
  • $250K Grant Awarded to Rutgers Cancer Institute of New Jersey Researchers
    $250K Grant Awarded to Rutgers Cancer Institute of New Jersey ResearchersJuly 31st, 2018
  • Rutgers Researchers Help Validate Discovery Method to Identify Antibodies That Target Tumors
    Rutgers Researchers Help Validate Discovery Method to Identify Antibodies That Target TumorsMay 3rd, 2018
  • Join now to see all

Grant Support

  • Regulation Of The Paracrine Angiogenic Function Of Cardiac Myocytes By CardiomyocNational Heart, Lung, And Blood Institute2011
  • Novel Clinical Diagnostic Targets For Detection Of Invasive MOLD AspergillosisNational Institute Of Allergy And Infectious Diseases2010–2011
  • Multifunctional Nanoassemblies For Ligand-Directed Imaging And Therapy Of EndocriNational Cancer Institute2010–2011
  • Molecular Targeting Of Lymphatic Endothelial Receptors For Ligand-Directed ImaginNational Cancer Institute2009–2010
  • Molecular Diversity In Bladder CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Mapping Vacular Diversity Of Human CancerNational Cancer Institute2005–2006
  • Imaging Tumor Blood Vessels In Bone Metastases From Breast CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
  • Stem Cell-Brain Tumor Interplay &In Vivo Phage DisplayNational Cancer Institute2003–2005
  • Mapping Vacular Diversity Of Human CancerNational Cancer Institute2004
  • Imaging Tumor Blood Vessels In Bone MetastasesNational Institute Of Diabetes And Digestive And Kidney Diseases2003
  • Molecular Heterogeneity Of Tumor Blood VesselsNational Cancer Institute2001–2002
  • Blood Vessel Targeting In Prostate Cancer TreatmentNational Cancer Institute2001–2002